139 related articles for article (PubMed ID: 35780954)
1. Ultrasound improved immune adjuvant delivery to induce DC maturation and T cell activation.
Wang X; Shi Z; Luo J; Zeng Y; He L; Chen L; Yao J; Zhang T; Huang P
J Control Release; 2022 Sep; 349():18-31. PubMed ID: 35780954
[TBL] [Abstract][Full Text] [Related]
2. Proton-Gradient-Driven Porphyrin-Based Liposome Remote-Loaded with Imiquimod as In Situ Nanoadjuvants for Synergistically Augmented Tumor Photoimmunotherapy.
Liu D; Fu L; Gong L; Li S; Li K; Liu K; Yang D
ACS Appl Mater Interfaces; 2024 Feb; 16(7):8403-8416. PubMed ID: 38334116
[TBL] [Abstract][Full Text] [Related]
3. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.
Luo J; Wang X; Shi Z; Zeng Y; He L; Cao J; Sun Y; Zhang T; Huang P
J Nanobiotechnology; 2022 May; 20(1):228. PubMed ID: 35568916
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma.
Ren S; Wang Q; Zhang Y; Song Y; Dong X; Zhang W; Qin X; Liu M; Yu T
Int Immunopharmacol; 2018 Nov; 64():69-77. PubMed ID: 30149266
[TBL] [Abstract][Full Text] [Related]
7. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
[TBL] [Abstract][Full Text] [Related]
8. Evaluating dendritic cells as an in vitro screening tool for immunotherapeutic formulations.
El-Murr T; Patel A; Sedlak C; D'Souza-Lobo B
J Immunol Methods; 2018 Aug; 459():55-62. PubMed ID: 29800576
[TBL] [Abstract][Full Text] [Related]
9. Multi-functional nanocomplex codelivery of Trp2 and R837 to activate melanoma-specific immunity.
Ji Z; Tan Z; Li M; Tao J; Guan E; Du J; Hu Y
Int J Pharm; 2020 May; 582():119310. PubMed ID: 32276088
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses.
Nijen Twilhaar MK; Czentner L; Bouma RG; Olesek K; Grabowska J; Wang AZ; Affandi AJ; Belt SC; Kalay H; van Nostrum CF; van Kooyk Y; Storm G; den Haan JMM
Front Immunol; 2022; 13():842241. PubMed ID: 35251040
[TBL] [Abstract][Full Text] [Related]
11. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice.
Zhao Y; Wang H; Yang Y; Jia W; Su T; Che Y; Feng Y; Yuan X; Wang X
Int J Nanomedicine; 2020; 15():9571-9586. PubMed ID: 33293808
[TBL] [Abstract][Full Text] [Related]
12. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
[TBL] [Abstract][Full Text] [Related]
13. An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production.
Ziegler A; Olzhausen J; Hamza E; Stojiljkovic A; Stoffel MH; Garbani M; Rhyner C; Marti E
Vet Immunol Immunopathol; 2022 Jan; 243():110351. PubMed ID: 34800874
[TBL] [Abstract][Full Text] [Related]
14. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
[TBL] [Abstract][Full Text] [Related]
15. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.
Klauber TCB; Laursen JM; Zucker D; Brix S; Jensen SS; Andresen TL
Acta Biomater; 2017 Apr; 53():367-377. PubMed ID: 28153581
[TBL] [Abstract][Full Text] [Related]
16. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
Sadeghlar F; Vogt A; Mohr RU; Mahn R; van Beekum K; Kornek M; Weismüller TJ; Branchi V; Matthaei H; Toma M; Schmidt-Wolf IGH; Kalff JC; Strassburg CP; González-Carmona MA
Cancer Immunol Immunother; 2021 May; 70(5):1451-1464. PubMed ID: 33180184
[TBL] [Abstract][Full Text] [Related]
17. Immunosonodynamic Therapy Designed with Activatable Sonosensitizer and Immune Stimulant Imiquimod.
Lei H; Kim JH; Son S; Chen L; Pei Z; Yang Y; Liu Z; Cheng L; Kim JS
ACS Nano; 2022 Jul; 16(7):10979-10993. PubMed ID: 35723442
[TBL] [Abstract][Full Text] [Related]
18. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.
Chen Q; Xu L; Liang C; Wang C; Peng R; Liu Z
Nat Commun; 2016 Oct; 7():13193. PubMed ID: 27767031
[TBL] [Abstract][Full Text] [Related]
19. The dynamic therapeutic effect of a targeted photothermal nanovaccine incorporating toll-like receptor 7 agonist enhanced cancer immunotherapy.
Karthikeyan L; Rithisa B; Vivek R
J Mater Chem B; 2023 Sep; 11(37):9005-9018. PubMed ID: 37712149
[TBL] [Abstract][Full Text] [Related]
20. Lymph node-targeted immune-activation mediated by imiquimod-loaded mesoporous polydopamine based-nanocarriers.
Wang L; He Y; He T; Liu G; Lin C; Li K; Lu L; Cai K
Biomaterials; 2020 Oct; 255():120208. PubMed ID: 32569862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
